1. Targeted inhibition of VEGF receptor 2: an update on ramucirumab;Clarke;Exp Opin Biol Ther,2013
2. FDA approval summary: ramucirumab for gastric cancer;Casak;Clin Cancer Res,2015
3. FDA Drug Label for CYRAMZA (ramucirumab) injection, for intravenous use. Accessed at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125477s034lbl.pdf June 18, 2020.
4. Decision making criteria in oncology;Glatzer;Oncology,2020
5. Clinicians’ expectations of the benefits and harms of treatments, screening, and tests: a systematic review;Hoffmann;JAMA Intern Med,2017